Failure of imidocarb dipropionate to clear experimentally induced Ehrlichia canis infection in dogs

Journal of Veterinary Internal Medicine

Volumn 20, Issue 4, 2006, Pages 840-844

  Eddleslone, Susan M ^a   Neer, T M ^a   Gaunt, S D ^b   Corstvet, R ^b   Gill, A ^b   Hosgood, G ^a   Hegarty, B ^c   Breitschwerdt, E B ^c  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b Pathobiological Sciences   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Canine ehrlichiosis; IFA; Imidicarb dipropionate; PCR; Platelets

Indexed keywords

BACTERIUM ANTIBODY; DRUG DERIVATIVE; IMIDOCARB; IMIDOCARB DIPROPIONATE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOG; DOG DISEASE; DRUG EFFECT; EHRLICHIA CANIS; EHRLICHIOSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE;

ANIMALS; ANTIBODIES, BACTERIAL; DOG DISEASES; DOGS; EHRLICHIA CANIS; EHRLICHIOSIS; IMIDOCARB; TREATMENT FAILURE;

CANIS; CANIS FAMILIARIS; EHRLICHIA; EHRLICHIA CANIS;

EID: 33645782355     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2006)20[840:FOIDTC]2.0.CO;2     Document Type: Article

References (14)

1. Iqbal Z, Rikihisa Y. Reisolation of Ehrlichia canis from blood and tissues of dogs after doxycycline treatment. J Clin Microbiol 1994;32(7):1644-1649.
2. Neer TM, Breitschwerdt EB, Greene RT. ACVIM consensus statement on ehrlichial disease of small animals from the Infectious Disease Study Group of the ACVIM. J Vet Intern Med 2002;16: 309-315.
3. Matthewman LA, Kelly PJ, Brouqui P. Further evidence for the efficacy of imidocarb dipropionate in the treatment of Ehrlichia canis infection. J South African Vet Assoc 1994;65(3): 104-107.
4. Ogunkoya AB, Adeyanju JB, Aliu YO. Experiences with the use of Imizol in treating canine blood parasites in Nigeria. J Small Anim Pract 1981;22:775-777.
5. Price JE, Dolan TT. A comparison of the efficacy of imidocarb dipropionate and tetracycline hydrochloride in the treatment of canine ehrlichiosis. Vet Rec 1980;107:275-277.
6. Sainz A, Tesouro MA, Amusategui I. Prospective comparative study of 3 treatment protocols using doxycycline or imidocarb dipropionate in dogs with naturally occurring ehrlichiosis. J Vet Intern Med 2000;14:134-139.
7. Van Heerden J, Van Heerden A. Attempted treatment of canine ehrlichiosis with imidocarb dipropionate. J South African Vet Assoc 1981;52:173-175.
8. Dawson JE, Biggie KL, Warner CK, Cookson K, Jenkins S, Levine J, Olson JG. Polymerase chain reaction evidence of Ehrlichia chaffeensis, an etiologic agent of human ehrlichiosis, in dogs from southeast Virginia. Am J Res 1996;57:1175-1179.
9. McBride JW, Yu X, Walker DH. A conserved, transcriptionally active p28 multigene locus of Ehrlichia canis. Gene 2000;254:245-252.
10. Gaunt S, Corstvet RE, Berry CM. Isolation of Ehrlichia canis from dogs following subcutaneous infection. J Clin Microbiol 1996;34(6):1429-1432.
11. Codner E, Ferris-Smith LL. Characterization of the subclinial phase of ehrlichiosis in dogs. JAVMA 1986;189(1):47-50.
12. Harrus S, Waner T, Aizenberg I. Amplification of ehrlichial DNA from dogs 34 months after infection with Ehrlichia canis. J Clin Microbiol 1998;36(1):73-76.
13. Bartsch RC, Greene RT. Post-therapy antibody titers in dogs with erhlichiosis: Follow-up study on 68 patients treated primarily with tetracycline and/or doxycycline. J Vet Internal Med 1996;10(4):271-274.
14. Harrus S, Waner T, Aizenberg I. Therapeutic effect of doxycycline in experimental subclinical canine monocytic ehrlichiosis: Evaluation of a 6-week course. J Clin Microbiol 1998;36(7): 2140-2142.